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Journal of the American Heart Association
ORIGINAL RESEARCH

Molecular and Cellular Differences in
Cardiac Repair of Male and Female Mice
Amanda B. Pullen, BS; Vasundhara Kain, PhD; Charles N. Serhan, PhD, DSc; Ganesh V. Halade

, PhD

BACKGROUND: Leukocyte-directed biosynthesis of specialized proresolving mediators (SPMs) orchestrates physiological inflammation after myocardial infarction. Deficiency of SPMs drives pathological and nonresolving inflammation, leading to heart
failure (HF). Differences in SPMs and inflammatory responses caused by sex-specific differences are of interest. We differentiated leukocyte-directed biosynthesis of lipid mediators in male and female mice, focusing on leukocyte populations, structural
remodeling, functional recovery, and survival rates.
METHODS AND RESULTS: Risk-free male and female C57BL/6 mice were selected as naïve controls or subjected to myocardial
infarction surgery. Molecular and cellular mechanisms that differentiate survival, heart function, and structure and leukocyte-
directed lipid mediators were quantified to describe physiological inflammation after myocardial infarction. Female mice show
improved survival in acute HF but no statistical difference during chronic HF compared with male mice. Female mice improved
survival is marked with functional recovery and limited remodeling compared with male mice. Male and female mice are similarly responsive to arachidonate lipoxygenase (LOX-5, LOX-12, LOX-15) or cyclooxygenase (COX-1, COX-2) in acute HF and
particularly male infarcted heart had overall increased SPMs. Female cardiac healing is marked with the biosynthesis of differential p450-derived product, particularly 11,12 epoxyeicosatrienoic acid in acute HF. A sex-specific difference of dendritic
cells in acute HF is distinct, with limited changes in chronic HF.
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CONCLUSIONS: Cardiac repair is marked with increased SPM biosynthesis in male mice and amplified epoxyeicosatrienoic acid
in female mice. Female mice showed improved survival, functional recovery, and limited remodeling, which are signs of fine-
tuned physiological inflammation after myocardial infarction. These results rationalize the sex-specific precise therapies and
differential treatments in acute and chronic HF.
Key Words: heart failure ■ ischemia ■ leukocytes ■ resolution of inflammation ■ specialized proresolving mediators

C

ardiovascular disease (CVD) is a leading cause of
death in the United States, with close to one third
of deaths being attributed to some form of cardiometabolic pathological feature.1,2 The primary risk
factors for CVD are related to several lifestyle aspects
that increase the likelihood of myocardial infarction
(MI; heart attack) in men and women. MI events are
less common in premenopausal women and occur
in men at an earlier age (≈65 years) compared with
women (≈72 years).3-5 The epidemiological study on
the autonomic response to CVD compounded with
obesity showed, although men and women are both

negatively impacted by obesity, some cellular and molecular mechanisms of these responses are sex specific and the overall mechanism is incomplete.6 There
are differences in the risk, timing, and symptoms of
heart disease between men and women for a variety of
pathological conditions; however, estrogen has been
linked to a higher survival rate of cardiomyocytes after
MI.7 Sex-specific differences in cardiovascular health
stem from multiple factors, including leukocytes, fat
immune metabolism, glycoprotein content, gene expression, sex hormones, and sociocultural aspects,
like behavior, environment, and nutrition.8–11
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CLINICAL PERSPECTIVE
What Is New?

• Leukocyte influx coordinates the biosynthesis
of specialized proresolving mediators for resolution of inflammation and timely cardiac repair
after myocardial infarction.
• In response to massive infarcts in male and female mice, leukocytes express higher levels of
lipoxygenase (5, 12, and 15) in the spleen and
heart, orchestrating the comprehensive bioactive lipid remodeling that is essential for the
resolution of inflammation in acute heart failure.
• Male and female mice equally biosynthesized
specialized proresolving mediators; however,
female mice generated higher levels of 11,12
epoxyeicosatrienoic acid to coordinate infarct
healing after myocardial infarction.

What Are the Clinical Implications?
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• With the current, prevailing view that leukocyte
density drives the inflammatory response, the
presented outcome supports the concept that
resolution (safe clearance of inflammation) is an
active process that coincides with the acute inflammatory phase of cardiac repair.
• Men and women are treated using similar therapeutic strategies in cardiovascular medicine,
and the measurement of sex-specific bioactive
lipid mediators may serve as predictive or prognostic and precise molecular and cellular markers for novel sex-specific therapeutic strategies
in patients.

Nonstandard Abbreviations and Acronyms
AHF
ALOX-12
ALOX-15
ALOX-5
ALX/FPR2
CHF
COX-1
COX-2
DHA
EET
HF
LV
LXB4
MI
SPMs

acute heart failure
lipoxygenase 12
lipoxygenase 15
lipoxygenase 5
lipoxin A4 receptor; formyl peptide
receptor
chronic heart failure
cyclooxygenase 1
cyclooxygenase 2
docosahexaenoic acid
epoxyeicosatrienoic acid
heart failure
left ventricle
lipoxin B4
myocardial infarction
specialized proresolving mediators (ie, lipoxin, resolvin, maresin,
and protectin families)

In response to cardiac injuries, such as MI, the
leukocyte-directed initiation of inflammation and activation of resolution programs facilitate the clearance
and repair of damage myocardium.12 Delayed initiation of inflammation or immune suppression causes
the late arrival of leukocytes to the site of infarction
and prolonged residual time of leukocytes during the
clearance process; when polymorphonuclear neutrophils are not cleared on time, it can lead to increased,
chronic inflammation.13–15 After experimentally inducing MI by coronary ligation, leukocytes biosynthesize endogenous specialized proresolving mediators
(SPMs) that are essential for cardiac healing and repair.12,16 SPMs are lipoxygenase-mediated omega 3
fatty acid derived biomolecules, including maresins,
protectins, resolvins, and lipoxins, that have been
shown to have a feed-forward effect on the adaptive immune system, leading to potential therapeutic uses to control inflammation and alleviate chronic
diseases.14,17,18 A positive-
feedback loop between
SPMs and leukocytes encourages the resolution of
injury-induced inflammation by increasing differential
lipoxygenase activity.19 Differences in SPMs between
men and women are still being uncovered; therefore,
we propose to investigate the differences of cardiac
healing in male and female mice with major emphasis
on leukocyte trafficking, endogenous bioactive lipid
mediators (including SPMs), heart structure, function,
and post-MI survival in acute heart failure (AHF) and
chronic heart failure (CHF). In the presented report,
we aim to explain the differences of male and female
C57BL/6J mice in 3 key aspects: (1) the signaling of
lipoxygenases and/or cyclooxygenases; (2) the biosynthesis of SPMs in regard to cardiac healing and
repair; and (3) cardiac healing in the context of physiological inflammation and resolution response. Our
report suggests that male and female mice operate
cardiac repair with the biosynthesis of SPMs differently. Male mice have increased overall SPM levels,
and female mice have amplified epoxyeicosatrienoic
acids (EETs) in AHF with increased levels of reparative macrophages.

METHODS
Data presented in this article support the findings of
this study and are available from the corresponding
author on reasonable request.

Animal Compliance
All animal procedures were conducted according to the National Institutes of Health Guide for the
Care and Use of Laboratory Animals (eighth edition,
2011) and were approved by the Institutional Animal
Care and Use Committees of University of South
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Florida (Tampa, FL) and University of Alabama at
Birmingham.

High-Resolution Transthoracic
Echocardiography
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In vivo cardiac performance of mice was assessed
using high-
resolution noninvasive echocardiography (Vevo 3100; VisualSonics, Canada) during which
mice were anesthetized using a 1-2% isoflurane and
100% oxygen mixture, administered with a small rodent respirator. Body hair on the dorsal side of each
animal was removed using depilatory cream at least
an hour before the imaging (Nair). Echocardiographic
measurement of cardiac structure and function was
performed with the high-resolution echocardiography analysis system Vevo 3100 equipped with MX
400 transducer (30 MHz) for small animals. Each
measurement was done by a single trained technician (A.B.P.) to eliminate interpersonal variation. Two-
dimensional B-mode short-a xis and long-a xis views,
along with B-mode tracings of the left ventricle (LV),
were obtained. Using analysis software provided by
the manufacturer, the following data were obtained:
LV dimension at systole and diastole, posterior wall
thickness at systole and diastole, interventricular
septal wall thickness at systole and diastole, LV volume at systole and diastole, LV stroke volume, ejection fraction, fractional shortening, heart rate, cardiac
output, global longitudinal and global circumferential
strain, and LV mass. In addition, the integrated monitoring system allowed measurement of physiological
parameters, such as body temperature, ECG, heart
rate, and respiration, to be captured and monitored
throughout an imaging session.20

Coronary Ligation Microsurgery to Induce
MI and Irreversible HF
The hair on the dorsal side of the animal was removed
before the surgery. Mice were anesthetized with a 2%
isoflurane and 100% oxygen mixture and secured to
the operating table. The MI was induced in the mice via
ligation of the left anterior descending artery using minimally invasive surgery, as previously described.21 A total
number of 71 mice were subjected to this surgery.20

Measurement of Post-MI Survival
After coronary ligation, mice were monitored closely
for recovery and survival monitor and classified into 3
categories. Perioperative mortalities included animals
that died during surgery or within the first 24 hours
after surgery. Mice that survived 24 hours after surgery
but died within 7 days were included within the AHF
survival curve. Mice that survived at least 8 days after
surgery but died before day (d) 56 were considered in

Cardiac Repair in Male and Female Mice

the CHF survival curve. A necropsy was performed on
the mice that died after 24 hours to determine if the
mortality was caused by a rupture of the LV or by CHF.
Ruptures included all mice with a tear or hole on the LV,
resulting in clotted blood within the chest cavity. CHF
deaths included mice with no apparent tear or clotted
blood in the chest cavity.4,20,22

Necropsy
Animals were anesthetized using a 2% isoflurane
and 100% oxygen mixture. From each animal, the
LV, lungs, spleen, and tibia were collected. The harvested tissues were either flash frozen and stored at
−70°C and used for Reverse transcription polymerase chain reaction and/or Western blot analysis or
placed in 10% zinc formalin and transferred to 70%
ethanol after 24 hours and used for histological analysis. The right ventricle was removed from the LV and
weighed. The LV was then separated into 3 pieces:
the infarct area (infarcted LV [LVI]) or ischemic area
below the ligation, the middle piece or the area that
has both infarct and remote areas, and the remote
area (remote LV) or the area not yet severely affected
by the ligation. The ischemic area of the LV and a
portion of the spleen were used for gene expression
and histological analysis and compared with naïve
controls. The lungs are weighed and then placed in
an incubator (37°C) for 24 hours, and dry weight is
recorded.20

Histological Analysis: Hematoxylin and
Eosin Staining
Sections of the LV at No-myocardial infarction (MI),
MI-d1, and MI-d56 were stained using hematoxylin
and eosin, and images were acquired using a BX43
microscope with an attached Olympus DP73 camera, as previously described.20

Confocal Microscopy for Fibrotic
Remodeling
For immunofluorescence, sections of the LV at MI-d5
were stained using α smooth muscle actin, discoidin
domain receptor 2, and Hoechst; and confocal images
were acquired using a Nikon A1 high-resolution microscope, as described previously.23

Leukocyte Quantitation Using Flow
Cytometry
The LV and spleen of No-MI (d0), MI-d1, MI-d3, and
MI-d56 male and female mice were taken; and mononuclear cells from both were isolated using methods as previously described.24 After adjusting for ≈1
to 2 million cells/stain, the cells were suspended in
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100 μL of FC block and allowed to incubate for 10 minutes on ice. A stain cocktail containing fluorophore-
labeled monoclonal antibodies in 2× concentration
was added on ice for 30 minutes. The stain cocktail contained CD45-PE-CY7 (BD Biosciences, San
Jose, CA), CD11b-
APC, F4/80-
PERCP (Molecular
Probes, Eugene, OR), Ly6C-FITC (BD Biosciences),
Ly6G–Pacific blue (e-
Bioscience), and LIVE/DEAD
Fixable Blue Dead Cell Stain Kit and was used to
determine viability and cell type (Figure S1A; gating
strategy).12,25

Quantitative Real-Time Polymerase Chain
Reaction of Gene Transcripts
RNA was isolated from both the LV and spleen of day
0 (d0) and MI-day 1 (MI-d1) male and female mice.
Reverse transcription was performed with 2.0 μg of
RNA using the SuperScript VILO cDNA Synthesis Kit
(Invitrogen, CA). The gene expression levels of COX1, COX-2, ALOX-5, ALOX-12, ALOX-15, IL-1β, TNF-α,
Arg-1, Mrc-1, ALX/FPR2, EP2, EP4, and EPHX-2 were
measured using TaqMan Probes (Applied Biosystems,
CA). The expressions were normalized using hypo
xanthine phosphoribosyltransferase 1 (HPRT1). The
results were reported using 2−∆Ct values.20
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Protein Extraction and Immunoblotting
Protein was extracted from the LVI or the remote
LV, as previously described.26 After electrophoresis
of 5 to 10 μg of LVI or remote LV protein, primary
antibodies ALOX-5, HO-1, COX-2, ALX/FPR2, TNFα, or GAPDH were allowed to incubate overnight at
4°C. After the incubation, respective secondary antibody (1:10 000 dilution in a 5% blocking solution)
was added, as previously described.26 Femto chemiluminescence detection system was used to detect
protein expressions (Pierce Chemical, Rockford, IL).
To normalize the total protein/lane, densitometry was
performed using Image J software (NIH, Bethesda,
MD).26

Quantification of SPMs Using Mass
Spectrometry
Samples of the LV and spleen for liquid chromatography–tandem mass spectrometry analysis were
obtained using solid phase extraction columns,
as described.12 To observe and measure the levels of lipid mediators in the LVI, an LC-tandem MS/
MS system, QTrap 5500 (ABSciex), equipped with an
Agilent HP1100 binary pump, was used. The Aligent
Eclipse Plus C18 column (50 mm×4.6 mm×1.8 μm or
100 mm×4.6 mm×1.8 μm) with a gradient of methanol/double-distilled H2O/acetic acid (60:40:0.001 to
100:0:0.01) was used at a flow rate of 0.5 mL/min. If
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a standard for a product was not available, a product
with similar chromatographic behaviors was used for a
calibration curve. Deuterium-labeled internal standards
included lipoxin A4, resolvin D1 (RvD1), Prostaglandin
E2 (PGE2), leukotriene B4, and others, obtained from
Cayman Chemical Company (Ann Arbor, MI) and used
to calculate recoveries. The peak area of each Multiple
Reaction Monitoring (MRM) transition and linear calibration curves were used for the quantification of each
mediator.27 A minimum of 6 characteristics and diagnostic ions were used for identification of all SPMs, in
accordance with published criteria of biologic and synthetic mediators.27,28

Statistical Analysis
The results are expressed as mean±SEM. Analyses
were performed using a 2-way ANOVA (mixed model);
multiple comparisons are done using Sidak test recommended parameter for time kinetics and post Tukey
test for other comparisons (Graphpad Prism 8.3.0
application). The Kaplan-Meier test and log-rank test
were followed for survival analysis. P<0.05 was considered as statistically significant.

RESULTS
Female Mice Have Higher Survival With
Few Ruptures in AHF
To determine the sex-specific differences between
male and female mice after permanent coronary ligation, we measured long-term survival, cardiac function, myocardium structural integrity, and gene and
protein expression (Figure 1A: study design). A total
of 43 male mice and 28 female mice were subjected
to occlusion of the left anterior descending coronary
artery. Successful MI and LV dilation were confirmed
using echocardiography within 24 hours after surgery with the inclusion criteria of fractional shortening <15%. Any mortalities within the first 24 hours
were considered perioperative mortalities and excluded from the survival curve (≈5% for the trained
surgeon). After analyzing the mortality rate of the
mice after MI using Kaplan-Meier curve, we separated the deaths into either AHF (MI-d1 to MI-d7) or
CHF (MI-d8 to MI-d56). Deaths in these categories
were further divided into HF or ruptures. In response
to coronary ligation, the overall survival in female
mice is 21% higher compared with male mice, without developing CHF or a rupture up to 56 days after
MI (Figure 1B and 1C). A breakdown of the survival
chart into the short-and long-term phases shows
that male mice have increased mortality attributable
to ruptures (28% compared with 7% in female mice)
and CHF (12% compared with 7% in female mice)
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Figure 1. Female mice have higher survival than male mice without ruptures or chronic heart failure (CHF) after myocardial
infarction (MI).
A, Study design to evaluate differences in male and female C57BL/6J mice after MI in acute heart failure (AHF) and CHF induced
by left anterior descending artery ligation. B, Survival rates of both sexes using the Kaplan-Maier test in AHF and CHF. C, Pie chart
showing the survival rates of both sexes. D and E, Bar graph showing the survival rates of both sexes in AHF and CHF. Males (n=43),
females (n=28). *P<0.02 vs male analyzed by log-rank test.
Downloaded from http://ahajournals.org by on August 20, 2020

within 7 days of MI (Figure 1D; Figure S1B). Within
the long-term phase (after MI-d7), there is no significant difference in either rupture or CHF mortalities
between male and female mice (Figure 1E; Figure
S1C). This in-depth survival analysis allowed for the
more accurate differentiation between male and female survival after MI and pinpointed the sex-specific
responses to AHF and CHF.

Female Mice Show Improved Recovery
and Heart Function After MI
Gravimetric parameters were measured to more accurately rule out variables between male and female
mice (Table 1). After the coronary ligation surgery,
echocardiograms of both male and female mice
showed reduced cardiac function consistent with HF
(Figure 2). In both sexes, LV dilation was evident by
the decrease in vector length (longitudinal and circumferential axis b-modes), increased strain on the
myocardium (strain), and myocardium dyssynchronicity (segmental synchronicity) of the representatives for
MI-d1 to MI-d56 compared with the No-MI controls
(Figure 2). However, after an initial decrease, female
mice recovered a portion of their cardiac function at
MI-d3, which continued to gradually increase until MI-
d56, shown by increased vector length (longitudinal

and circumferential axis b-modes), decreased muscle
strain (strength), and improved synchronicity (segmental synchronicity) (Figure 2). The improvement of
the female mice heart function is further shown by the
increase in their fractional shortening (MI-d56: 19%
in females compared with 8% in males) and global
longitudinal strain (MI-
d56: −11% in females compared with −6% in males) (Table). Thus, improvement
in heart functional recovery is believed to be enabling
the female mice to “bounce back” and survive at a
significantly higher rate than male mice after MI.

Cardiac Tissue Repair Marked With SPM
Biosynthesis With Higher Levels of EETs
in Female Mice
After discovering the higher survival in females is
caused by lower rupture rates in AHF, we quantified
the levels of proinflammatory mediators, endogenous
SPMs, and EETs in the LVI at d1 after MI (Figure 3A
through 3F and Figure S2). The arachidonic acid–
derived proinflammatory mediators, such as leukotriene B4, Prostaglandin (PG)D2, PGE2, PGF2α, and
Thromboxane B2 (TXB2), were increased in both male
and female mice as signs of initiation of an inflammatory response (Figure S3) and simultaneous biosynthesis of SPMs as resolving response (Figure S4). The
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Figure 2. Female mice show better recovery of function and synchronicity from MI-d1 to MI-d 56.
Speckle tracking-based echocardiography representatives of male and female mice at No-MI, MI-d1, and MI-d56 (from left: longitudinal
axis 2-dimensional [2D] B-mode, longitudinal 3-dimensional [3D] strain, longitudinal segmental synchronicity graph with displayed
curves, and longitudinal time to phase; short axis 2D B-mode, circumferential 3D strain, circumferential segmental synchronicity
graph with displayed curves, and circumferential time to phase). Males (n=5-18), females (n=5-19).

pie chart distribution of SPMs reflects high SPM cluster in male mice (17%) compared with female mice
(11%) in LVI (Figure 3C and 3D). The individual quantification of D-series resolvins, maresins, protectins,
and arachidonic acid–derived SPMs suggests male
and female mice biosynthesis of SPMs with activation
of proinflammatory mediators, suggestive of overlapping inflammation-resolution response in cardiac
repair (Figure 3A through 3E). The female mice have
higher levels of p450-
mediated arachidonic acid–
derived EET compared with the male counterparts,
specifically a significant (1.3 fold; P<0.05) increase
in 11,12-EETs (Figure 3F). The quantitative analyses
of endogenous bioactive lipids suggest that despite
similar SPM contributions in cardiac repair, females
have the tendency to produce higher levels of arachidonic acid–derived cypoxins (EETs) compared with
the males in infracted LV in AHF after MI.

Differential Lipoxygenase and
Cyclooxygenase Activation in Male and
Female Mice in AHF
After myocardium injury, cyclooxygenase (COX-1 and
COX-2) and arachidonate lipoxygenase (ALOX-5,

ALOX-12, and ALOX-15) activity increases at the site
of infarction. To determine the differences in initiation
of inflammation-resolution between male and female
mice, the expression of cyclooxygenases and lipoxygenases was quantified from the spleen and LV for
the following time points: No-MI, MI-d1, and MI-d56
(Figure 4A through 4M). At MI-d1, ALOX-5 had higher
expression in the male spleen compared with females
(Figure 4A). In response to cardiac injury, immune responsive lipoxygenases (5, 12, and 15) and cyclooxygenases (1 and 2) are amplified at MI-d1 in both the
LV and spleen as signs of inflammatory and beginning of resolution signal for the biosynthesis of SPMs
(Figure 4A through 4J). Female splenic and LVI expressions of COX-1 are higher than male expression at MI-
d1 (Figure 4G and 4I). Expression of COX-2 showed no
difference between the males and females (Figure 4H
and 4J). The expression levels of lipoxygenases and
cyclooxygenases in the spleen and LV of male and
female mice returned to the normal, homeostatic levels at MI-d56 as a signal of physiological control and
resolved inflammation (Figure 4A through 4J). LV protein levels show male mice produce more ALOX-5 and
COX-2 at MI-d1 compared with female mice (Figure 4K
through 4M). These results indicate the spleen and
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Figure 3. Both sexes biosynthesized similar amounts of specialized proresolving mediators (SPMs) after cardiac injury.
A, Bar graph showing the docosahexaenoic acid (DHA) series resolvins of the left ventricle at myocardial infarction (MI)-day (d1 of male and
female mice. B, Bar graph showing the arachidonic acid (AA)–derived SPM moieties of the left ventricle at MI-d1 of male and female mice.
C, Pie chart showing the SPMs (resolvins, protectins, maresins), epoxyeicosatrienoic acids (EETs), and AA-derived SPMs in the left ventricle
of male mice at MI-d1. D, Pie chart showing the SPMs (resolvins, protectins, maresins), EETs, and AA-derived SPMs in the left ventricle of
female mice at MI-d1. E, Bar graph showing the protectins and maresins of the left ventricle at MI-d1 of male and female mice. F, Bar graph
showing the EETs of the left ventricle at MI-d1 of male and female mice (MI-d1: males [n=3], females [n=4]). *P<0.05 vs male MI-d1.

infarcted heart coordinate endogenous biosynthesis of
lipid mediators in cardiac repair during acute myocardial injury.

Distinct Reparative Structural Remodeling
in Female Mice in AHF
Adverse myocardium structural remodeling is a primary risk factor for CHF after MI. To define recovery, we examined hematoxylin and eosin stained
LV sections at No-MI controls, MI-d1, and MI-d56
(Figure 5A). For each MI time point, we examined the
remote (noninfarcted area after MI), peri-infarct (the
area between the remote and infarct), and the infarct
(thin-wall area of the myocardium) areas to get an accurate representation of the progression of cell apoptosis and cardiac repair. The remote areas at the
No-MI and MI-d1 time points of both the male and female mice show parallel cardiomyocyte, elongate, and
centrally located nuclei and intercalated disks in myocardium structure (Figure 5A). However, at MI-d56,
the tissue damage has expanded to the remote area
and the peri-infarct and infarct areas, with persistent
scar within the myocardium structure, and the nonmyocyte nuclei are misplaced and are congregated

within the dead tissue, decreasing structural integrity
and aligning with the CHF phenotype (Figure 5A). No
difference was observed in the cardiomyocyte area
between male and female mice (Figure S5). Fibrotic
remodeling further confirmed by α smooth muscle
actin and discoidin domain receptor 2 staining to determine fibroblast activation and presence of collagen
in AHF at MI-d5 (Figure 5B). The female LVI showed
lower expression of α smooth muscle actin and discoidin domain receptor 2 compared with male LVI, indicating limited fibrotic remodeling (Figure 5B). Thus,
limited fibrotic and structural remodeling in female
mice supports the improved functional recovery and
survival in both AHF and CHF.

Reparative Monocytes Are Higher in
Female Mice Compared With Male Mice
After MI
Initiation of inflammation in AHF is defined by the
entry of leukocytes at the site of injury with continuum
phenotype spectrum; therefore, we analyzed how
sex-specific differences impacted LV leukocyte populations after MI using flow cytometry during AHF and
CHF24 (Figure S6). At naïve homeostatic setting, male
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Figure 4. Male mice have a higher level of lipoxygenase (LOX) expression, whereas female mice express higher
cyclooxygenases (COXs) after MI.
A through F, Line graphs of LOXs (ALOX5, ALOX12, ALOX15) in the spleen and left ventricle of male and female mice from No-MI to
MI-d1. G through J, Bar graphs of COXs (COX1, COX2) in the left ventricle of male and female mice from No-MI to MI-d1 (no-MI: males
[n=4], females [n=4]; MI-d1: males [n=6], females [n=6]). *P<0.05 vs no-MI naïve controls; $P<0.05 vs male at respective time point. K
through M, Western blot representative and bar graphs of protein expression of ALOX5 and COX2 (n=3/group). *P<0.05 vs no-MI naïve
controls; $P<0.05 vs male at respective time point.

and female mice show no difference in LV monocyte
(CD45+/CD11b+) populations. In response to ischemic
insult, male and female monocytes consistently amplified from d1 to d5 after MI. In both male and female
mice, monocyte populations declined at d56 (CHF),
comparative to pre-MI naïve state. Female mice showed
lower monocytes (53±4.3%; P<0.05) when compared
with the male mice (68±3.9%) in AHF (after MI-
d5)
(Figure 6A through 6G). Although, in both male and female mice, monocyte population declined at d56 after
MI (CHF), in females, monocyte population was significantly higher (16.0±2.1%) compared with the male
counterpart, which displayed (1.6±0.2%) of monocytes
(Figure 6A and 6E). However, no sex-specific changes
in CD11b+ expression were observed (Figure 6B).
Furthermore, the phenotypic analysis of LV monocytes
on basis of Ly6Clo and Ly6Chi displayed female mice
had a higher Ly6Clo population (18±0.7%), compared
with male mice (14±0.7%) at d1 after MI, which remained significantly higher in CHF (Figure 6C, 6D, 6F,
and 6G). Increased reparative monocytes during AHF
support the improved cardiac repair, functional recovery, and limited fibrotic remodeling of female mice.

Female Mice Have Intensified Dendritic
Cell Activation in Cardiac Repair Than
Male Mice After MI
After the ischemic insult, dendritic cells (DCs) are an
essential part of the innate immune leukocyte system.
DCs act as a bridge to the adaptive immune system
and play a tissue reparative role in cardiac healing,
as the inadequate levels of DCs led to increased rupture and impaired reparative fibrosis after MI.29 In the
absence of cardiac injury (No-MI), no difference was
observed in CD11c-positive cells between male and
female mice (Figure 7A and 7E). In response to coronary ligation, there was a consistent increase in CD11c
cells in AHF (MI-d1, MI-d3, MI-d5) and a CD11c+ cell
population decline at CHF (MI-
d56), irrespective of
sex-specific. At post–MI-d1, female mice displayed a
higher percentage of CD11c+ cells (3.2±0.5%) compared with male mice (1.8±0.2%), and the DC population peaked at d5 and remained significantly higher in
females. Compared with AHF, the DC population declined with time in CHF but relatively remained higher
in females compared with males (Figure 7A, 7B, and
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Figure 5. Female mice display a lower level of α-smooth muscle action (α-SMA) compared with male mice at d5 after MI
with similar intensity of remodeling.
A, Representative hematoxylin and eosin stained left ventricular (LV) images from d0 naïve control (No-MI); MI-d1 is suggestive of acute
heart failure (HF), and MI-d56 is indicative of chronic HF in male and female mice. Representative images of remote (left), peri-infarct
(middle), and infarct area (right) with a magnification of ×40 and accompanying ×1.25 images (n=4-5 mice/group/day; bar=50 μm).
B, Immunofluorescence images indicating reduced α-SMA (red) and discoidin domain receptor 2 (DDR2; green) expression in LV of
females at d5 after MI. Nuclei are stained with Hoechst (blue) (bar=500 μm).

7E). As expected, the neutrophils are the first phagocytic responder in cardiac injury. The quantitative analyses of neutrophil populations from male and female
mice showed that neutrophils peaked at post–MI-d3
and reached the homeostatic level at d56 after MI. The
percentage neutrophil population showed no statistical
difference in male and female mice in the infarcted area
(Figure 7C, 7D, and 7F).
Analysis of macrophage kinetics (CD45+CD11b+
F4/80+) showed a peak at MI-d5, with a decline in their
population at MI-d56. However, male and female mice
displayed a similar percentage of macrophage populations (Figure S6A trough S6E). The macrophages
are subclassified as Ly6Clo and Ly6Chi, indicative of
their proinflammatory and/or proreparative function,
so we quantified F4/80+ cardiac macrophages after
MI by Ly6Clo/hi expression. Males and females equally
amplified the Ly6Chi population, but females displayed
a higher population of Ly6Clo cells (8.5±1.3%) compared with males (1.1±0.1%) at post–MI-d56, contributing to improved cardiac repair (Figure S6B and S6F).
Leukocyte-directed physiological inflammation in the
female is marked with activation of reparative monocytes and macrophages, with an amplified density
of DCs in short-term cardiac repair with the limited

difference in CHF. This male and female leukocyte diversity suggests physiological cardiac repair in females
expedited by the presence of a higher number of DCs
and reparative monocytes and macrophages in AHF.

Female Mice Activate the Inflammation-
Resolution Sensor and Cytokines in the
LVI After MI
To define cardiac healing in AHF and CHF, the differences in cytokines and the bioactive lipid mediator
receptors of male and female mice and the levels of
proinflammatory and inflammation controlling cytokines within the spleen and LVI at MI-d1 were measured. The male mice showed increased expression
of TNF-α, IL-1β, ARG-1, and MRC-1 within the spleen
(Figure 8A through 8D); and the female mice showed
higher expression of the same cytokines within the LVI
at MI-d1 (Figure 8E through 8H). The male mice showed
higher protein levels of TNF-α in the LVI compared with
females, indicating divergence in the levels of RNA and
protein (Figure 8I and 8J). Male mice also had increased
expression of HO-1 in the LVI (Figure 8K). Furthermore,
we determined receptors (ALX/FPR2, EP2, and EP4)
and cypoxins (EETs) metabolizing enzyme (EPHX2)
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Figure 6. Female mice show higher reparative monocytes compared with male mice after myocardial infarction (MI).
(A) Plot showing cluster of differentiation (CD)11b+ (monocytes) cells at No-MI, MI-d3, MI-d5, and MI-d56 in male and female mice. (B)
Histograms showing monocytes expression at No-MI, MI-d3, MI-d5, and MI-d56 in male and female mice. (C) Plot showing cluster
of Ly6Chi and Ly6Clo cells at No-MI, MI-d3, MI-d5, and MI-d56 in male and female mice. (D) Histograms showing Ly6Chi and Ly6Clo
monocytes expression at No-MI, MI-d3, MI-d5, and MI-d56 in male and female mice. (E, F, G) Line graphs showing the percentage of
the cell population for CD11b, Ly6Chi monocytes (MO), and Ly6CloMO. [No-MI: males (n=4), females (n=4); MI-d1: males (n=5), females
(n=6); $P<0.05 vs male at respective time point; *P<0.05 compared with no-MI naïve controls.

gene expression within the spleen and LVI and found
minor sex-specific differences in levels of ALX/FPR2,
EP4, EP2, and EPHX2 within the spleen (Figure 9A
through 9D). In infarcted heart, ALX/FPR2 and EP4
activation were significant in female mice, suggestive
of amplified receptor activation in female mice during
cardia repair (Figure 9E through 9H).

DISCUSSION
After the ischemic insult, unresolved inflammation-
directed HF has increasingly become one of the main
causes of death, both within the United States and
worldwide; however, the differences in how HF is
presented and managed between men and women
have been inadequately investigated. The major risk
factors for CVD are universal and independent of
sex and can include aging, obesity, hypertension,
diabetes mellitus, alcohol consumption, and smoking.9,30 Regardless of this, women are less likely to
develop CVD or HF compared with men, unless they
are significantly older.30–32 In addition, hypertension

has a greater impact on men developing HF than
women.30 To define physiological inflammation and
cardiac repair in the absence of diversified risk factors, we described leukocyte-directed molecular and
cellular differences in male and female mice. Our key
findings are as follows: female mice (1) have higher
survival and lower rupture rates; (2) have amplified reparative monocytes, DCs, and macrophages; and (3)
produced higher levels of EETs compared with male
mice during the cardiac repair. Our functional and
molecular analysis provides understanding about the
difference between male and female mice in cardiac
repair (Figure 9I).
Differences in cardiovascular morbidity and mortality caused by sex have not been adequately researched. Most mortalities develop with age, and
several reports have only studied young mice in this
context. Therefore, studies on phenotypical determinations need to balance sex ratios to avoid misleading information when a sex difference does exist. Our
study showed the overall survival after MI is higher
in female mice compared with male mice, which is
in accordance with humans, where women have a
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Figure 7. Female mice intensified leukocyte response compared with male mice after myocardial infarction (MI).
(A) Plot showing dendritic cells (CD11c+) at No-MI, MI-d3, MI-d5, and MI-d56 in male and female mice. (B) Histograms showing
dendritic cells at No-MI, MI-d3, MI-d5 and MI-d56 in male and female mice. (C) Plot showing neutrophils (Ly6G+) at No-MI, MI-d3, MId5, and MI-d56 in male and female mice. (D) Histograms showing neutrophils expression at No-MI, MI-d3, MI-d5 and MI-d56 in male
and female mice. (E, F, G) Line graphs showing the percentage of the cell population of CD11c and Ly6G. [No-MI: males (n=4), females
(n=4); MI-d1: males (n=5), females (n=6); $P<0.05 vs male at respective time point; *P<0.05 compared with no-MI naïve controls.

lower risk for HF than men.31,33 It was well noted that
major differences in the survival rates between the
male and female mice occur during AHF, whereas
both male and female mice showed no difference
in survival rates during CHF. This study showed female mice having a rupture rate of 7%, whereas in
male mice, rupture rates were 28% in AHF. In recent decades, research on sex-related differences
in cardiovascular medicine has been focused on
demonstrating the role of hormones, but leukocyte
phenotypes and their population differences caused
by sex remained understudied.
The post-MI leukocyte-derived growth factors, cytokines, and different mediators are major contributors
to inflammation and resolution. Moreover, leukocyte
populations differ considerably within male and female
mice during clot formation and AHF.12,34,35 Female mice
showed higher population of reparative monocytes
and macrophages (Ly6Clo monocytes and Ly6Clo
macrophages), indicative of healing response.12,36
Studies have demonstrated that DC numbers increase
in infarcted hearts of experimental models,37 and decreased numbers of DCs in human infarcted myocardial
tissue are associated with impaired reparative fibrosis
and the development of cardiac ruptures after MI.29

Female mice not only displayed high DC populations at
both AHF and CHF, which provides early inflammation-
resolution benefits and plays a role in fibrotic repair.
DC infiltration in human infarcted myocardium showed
a strong association between the number of DCs and
impaired reparative fibrosis, leading to the development of cardiac rupture, and suggests a protective role
of DCs during the post-MI cardiac repair process.29 In
humans, women amplify D-series resolvin biosynthesis compared with men to terminate systemic inflammation induced by typhoid vaccine, which confirms
sex-specific SPM differences.4 In mice, male and female equally biosynthesized SPMs with leukocyte
expressed lipoxygenase activation after MI. However,
although the female mice have increased inflammatory
cytokines (TNF-α, IL-1β, ARG-1, and MRC-1) within the
infarcted heart at day 1 after MI, the males have increases of the same cytokines within the spleen, indicating a difference in cardinal reaction of inflammation
or reaction time between the male and female mice.
This could also explain the lower rupture rates in female mice. Female mice also have a higher expression
of receptors (ALX/FPR2 and EP4) within the LVI at MI-
d1, indicating an increased ability to bind to both proinflammatory and proresolving ligands, supporting the
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Figure 8. Male mice have increased expression of cytokines in the spleen, female mice have increased expression of
cytokines in the left ventricle.
(A-D) Bar graphs of increased tumor necrosis factor (TNF)-α, interleukin (IL)-1β, Arginase 1 (ARG-1), Mannose Receptor C-Type 1
(MRC-1) in the spleen of male mice from no-MI to MI-d1. (E-H) Bar graphs of increased TNF-α, IL-1β, ARG-1, MRC-1 in the left ventricle
of female mice from no-MI to MI-d1. no-MI: males (n=4), females (n=4); MI-d1: males (n=6), females (n=6); *P<0.05 compared with
no-MI naïve controls, $ P<0.05 vs male at respective time point. (I-K) Western representative and bar graphs of expression of TNF-α
and heme oxygenase-1 (HO1). [(n=3/group); *P<0.05 compared with no-MI naïve controls, $ P<0.05 vs male at respective time point.

cardiac repair and recovery of the myocardium. Pain
and inflammation are an obvious response to injury
and wound healing, particularly resolvin D5 as one of
the SPM moiety control chemotherapy-induced pain
in females compared with males; thus, additional SPM
investigation is warranted for precise and personnel
sex-specific treatment.38
Cardiac healing after a heart attack is marked with
overlapping inflammation and resolution processes
that are initiated when leukocytes arrive at the site of
infarction.12 Historically, the resolution was considered
as a passive event not considered as an active program and is coordinated by immune responsive leukocyte expressed lipoxygenase activation and interaction
with essential fatty acids.12,39,40 Quantitative analyses
of leukocyte-directed SPMs (D-E series resolvins, protectins, maresins, and lipoxins) and cytochrome P450
epoxygenases mediated EETs suggest that male and
female mice equally respond to the biosynthesis of
SPMs. Of note, females biosynthesize higher levels of
11, 12 EETs compared with males. EETs manage microenvironment during inflammatory response, which
favors macrophage reparative phenotype essential for

cardiac healing and repair.22,41,42 The improved cardiac
function and better survival in young risk-free female
mice is attributable to the confounding factors associated with endogenous biosynthesis of the EET-enriched
microenvironment. In this report, females mice have a
longer survival with HF with a similar prevalence of HF
than males. However, the outcome may change when
various other risk factors (ie, processed and packed
food intake, age, comedication, and metabolic defects)
exist in preclinical or clinical setting.21,23,43,44 Several
reports have only studied mice at a young age, and it
remains unknown if sex differences occur in other studies when research extends to aging animals with overlapping risk factors, such as obesity, insulin resistance,
hyperglycemia, or high blood pressure.2

Strengths
The presented study provided sex-specific temporal
evidence with quantitative levels of bioactive lipid mediators in AHF and CHF. Survival, functional recovery,
and leukocyte-directed cardiac repair that showed sex-
specific signs of fine-tuned physiological inflammation
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Figure 9. Both sexes have differential expressions of receptors and enzymes in the spleen and left ventricle.
(A-D) Bar graphs of differential levels of N-formyl peptide receptor 2(ALX/FPR2), prostaglandin E2 receptor 4 (EP4), Prostaglandin
E2 receptor 2 (EP2), Epoxide Hydrolase 2 (EPHX2) in the spleen of male and female mice from no-MI to MI-d1. (E-H) Bar graphs of
increased levels of ALX/FPR2, EP4, EP2, EPHX2 in the left ventricle of female mice from no-MI to MI-d1. no-MI: males (n=4), females
(n=4); MI-d1: males (n=6), females (n=6); *P<0.05 vs no-MI naïve controls, $ P<0.05 vs male at respective time point. (I) Summary sketch
showing the overall survival, function, and structure, and cellular and molecular changes between male and female mice in cardiac
repair process.

in female mice without the risk factors that are common in a clinical setting (Figure 9I).

Limitations and Perspective
In women, estrogen levels and leukocyte activity during the menstrual, proliferative, and secretary phases
of menstrual cycle vary and remain uncovered in mice
cardiac injury experiments.45 In addition, the significance of some sex-related phenotype diversities warrants further investigation.
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Figure S1. (A) Gating strategy for flow cytometry. (B-C) Donuts pie chart showing the survival
rates of both sexes in acute and chronic HF.
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Figure S2. Heat map showing differential quantity of specialized pro-resolving mediators
(SPMs) and epoxyeicosatrienoic acid (EETs) in male and female mice.
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Figure S3. Biosynthesis of arachidonic acid (AA)-derived proinflammatory mediators in
male and female mice post-MI. (A) Pie chart showing the AA-derived proinflammatory mediators
in the left ventricle of male mice at MI-d1. (B) Pie chart showing the AA-derived proinflammatory
mediators in the left ventricle of female mice at MI-d1. (C) Bar graph showing AA-derived
proinflammatory mediators of the left ventricle at MI-d1 of male and female mice. MI-d1: males
(n=3), females (n=4).
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Figure

S4.

Endogenous

biosynthesis

of

docosahexaenoic

acid

(DHA)

and

eicosapentaenoic acid (EPA)-derived SPM precursors in male and female mice post-MI (A)
Pie chart showing the DHA and EPA precursors in the left ventricle of male mice at MI-d1. (B) Pie
chart showing the DHA and EPA precursors in the left ventricle of female mice at MI-d1. (C) Bar
graph showing DHA and EPA precursors of the left ventricle at MI-d1 of male and female mice.
MI-d1: males (n=3), females (n=4).
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Figure S5. Structural changes in cardiomyocyte area. Wheat germ agglutinin (WGA) staining
showing cardiomyocyte area in male and female mice. WGA = green, Hoechst = blue, [No-MI:
males (n=4), females (n=4); MI-d1: males (n=5), females (n=6); MI-d56: males (n=4), females
(n=4).
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Figure S6. Female mice have higher reparative macrophages (MΦ) compared to male
mice post-MI. (A) Plot showing macrophages at No-MI, MI-d1, MI-d3, MI-d5, and MI-d56 in
male and female mice. (B) Plot showing Ly6Clo and Ly6Chi macrophages at No-MI, MI-d1, MId3, MI-d5, and MI-d56 in male and female mice. (C-E) Line graphs showing the percentage of
the cell population for CD11b, Ly6ChiMΦ, and Ly6CloMΦ. [No-MI: males (n=4), females (n=4);
MI-d1: males (n=5), females (n=6); $p<0.05 vs male at respective time point; *p<0.05 compared
to no-MI naïve controls.
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